Valuation Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. Other stock markets 03/08/2026			5-day change	1st Jan Change
978.41 ^PKR	-0.51%		-2.15%	-4.31%

19/05	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
30/04	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	48,650	54,175	51,839	-	-
Change	-	11.36%	-4.31%	-	-
Enterprise Value (EV)	48,650	54,175	51,839	51,839	51,839
Change	-	11.36%	-4.31%	0%	0%
P/E	14.4x	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	1.96x	1.71x	1.52x	1.35x
EV / Revenue	-	0x	1.71x	1.52x	1.35x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	50	45	52	60
Rate of return	-	4.89%	4.6%	5.31%	6.13%
EPS ²	63.95	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	27,706	30,398	34,163	38,399
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	3,389	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	918.22	1,022.49	978.41	978.41	978.41
Nbr of stocks (in thousands)	52,983	52,983	52,983	-	-
Announcement Date	26/03/25	07/04/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHNOON LABORATORIES LIMITED	-	-	-	4.6%	19Cr
ELI LILLY AND COMPANY	34.19x	11.9x	25x	0.6%	1LCr
JOHNSON & JOHNSON	27.59x	6.24x	17.41x	2.11%	61TCr
ABBVIE INC.	33.42x	7.23x	14.91x	2.82%	43TCr
ROCHE HOLDING AG	19.84x	4.71x	11.66x	2.81%	35TCr
NOVARTIS AG	21.78x	5.64x	14.07x	2.85%	29TCr
ASTRAZENECA PLC	19.76x	4.1x	11.62x	2.15%	24TCr
NOVO NORDISK A/S	13.29x	4.98x	10.27x	3.76%	21TCr
AMGEN INC.	24.88x	6.52x	11.5x	2.66%	20TCr
GILEAD SCIENCES, INC.	-47.26x	5.67x	31.29x	2.51%	16TCr
Average	16.39x	6.33x	16.42x	2.69%	35.01TCr
Weighted average by Cap.	23.92x	7.55x	17.90x	2.05%